Nvidia-Backed Iambic Therapeutics Files for Nasdaq IPO as ‘IAM’By Martin Holloway22/09/2026 Iambic Therapeutics, backed by Nvidia and Qatar’s sovereign fund, has filed for a Nasdaq IPO under ticker IAM to fund cancer drug trials.
